What it's for (Indications)
- Theophylline is indicated as a bronchodilator for the symptomatic treatment of acute and chronic bronchial asthma, as well as for reversible bronchospasm associated with chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis.
- Its primary role involves relaxing the smooth muscles of the bronchi and pulmonary blood vessels, thereby improving airflow and reducing the work of breathing.
- While its use has somewhat declined due to the development of other bronchodilators with more favorable safety profiles, sustained-release formulations, such as Respro SR, are still utilized for long-term maintenance therapy in patients who do not achieve adequate symptom control with alternative therapies or as an add-on agent.
- It is crucial to note that theophylline is not recommended for the relief of acute bronchospasm but rather for its prevention and chronic management.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage of theophylline must be highly individualized and carefully titrated to achieve therapeutic serum concentrations, typically ranging from 5 to 15 mcg/mL in adults, while minimizing the risk of adverse effects. Due to significant inter-individual variability in metabolism, initial dosing should always be conservative, especially with sustained-release preparations like Respro SR, which are typically administered once or twice daily. Subsequent dose adjustments must be guided by clinical response and, most importantly, by regular monitoring of serum theophylline levels. Factors such as age, smoking status, concomitant medications (e.g., cimetidine, erythromycin, ciprofloxacin, phenobarbital, phenytoin), concurrent illnesses (e.g., hepatic dysfunction, congestive heart failure, fever, hypothyroidism, hyperthyroidism), and dietary habits can profoundly influence theophylline clearance and necessitate significant dose modifications. Patients should be instructed to take their medication consistently with respect to food and timing. |
Safety & Warnings
Common Side Effects
- Theophylline has a narrow therapeutic index, increasing the propensity for adverse reactions, which are often concentration-dependent.
- Common side effects, particularly when serum levels exceed the therapeutic range or during rapid dose escalation, include gastrointestinal disturbances such as nausea, vomiting, epigastric pain, and diarrhea.
- Central nervous system manifestations may include headache, insomnia, restlessness, irritability, and tremor.
- More serious and potentially life-threatening adverse events, typically associated with toxic serum concentrations (generally >20 mcg/mL), involve the cardiovascular system (e.
- g.
- , supraventricular tachycardia, ventricular premature beats, ventricular fibrillation, hypotension) and the central nervous system (e.
- g.
- , generalized tonic-clonic seizures, coma).
- These severe reactions can occur abruptly without preceding milder symptoms, necessitating immediate medical attention and discontinuation of the drug.
Serious Warnings
- Black Box Warning: While theophylline does not carry a formal FDA Black Box Warning, it is crucial to recognize its narrow therapeutic index, which necessitates extreme caution and vigilant monitoring. The difference between therapeutic efficacy and serious toxicity is small. Life-threatening adverse events, including cardiac arrhythmias (e.g., ventricular fibrillation) and generalized tonic-clonic seizures, can occur abruptly and without any preceding mild toxicity symptoms, even at serum concentrations within or slightly above the conventional therapeutic range (5-15 mcg/mL). Various factors, such as acute illnesses (e.g., viral infections, fever), concurrent medications, age (especially elderly patients), and organ dysfunction (e.g., hepatic or congestive heart failure), can dramatically alter theophylline clearance, leading to rapid and unexpected accumulation to toxic levels. Therapeutic drug monitoring is essential to minimize these severe risks, and patients must be thoroughly educated about the signs of toxicity and the critical importance of strict adherence to prescribed dosing and prompt reporting of any changes in health status or concomitant medication use to their healthcare provider.
- Theophylline should be used with extreme caution in patients with cardiovascular disease (e.
- g.
- , unstable angina, acute myocardial infarction, severe hypertension, arrhythmias), active peptic ulcer disease, seizure disorders, hyperthyroidism, or acute viral illnesses (especially those accompanied by fever).
- These conditions can either increase the patient's susceptibility to adverse effects or significantly alter theophylline metabolism, leading to elevated serum concentrations and heightened toxicity risk.
- Elderly patients, those with hepatic impairment, or individuals with congestive heart failure exhibit reduced theophylline clearance and require lower doses and diligent therapeutic drug monitoring.
- Smoking cessation drastically reduces theophylline clearance, necessitating a substantial dose reduction.
- Numerous drug interactions can occur, significantly impacting theophylline levels, so careful review of all concomitant medications is essential.
- Patients must be educated about the importance of not exceeding prescribed doses and reporting any new symptoms or changes in health status.
How it Works (Mechanism of Action)
Theophylline exerts its primary therapeutic effects through multiple complex mechanisms. It functions as a non-selective phosphodiesterase (PDE) inhibitor, particularly inhibiting PDE3 and PDE4. This inhibition leads to an increase in intracellular cyclic adenosine monophosphate (cAMP) levels in bronchial smooth muscle cells, promoting smooth muscle relaxation and subsequent bronchodilation. Additionally, theophylline acts as a non-selective antagonist of adenosine receptors (A1, A2A, A2B, A3). By blocking adenosine, it counteracts adenosine-induced bronchoconstriction, suppresses the release of inflammatory mediators, and may modulate central nervous system activity. Theophylline also contributes to anti-inflammatory effects by enhancing histone deacetylase activity, which plays a role in suppressing the expression of inflammatory genes. Other proposed mechanisms include modulation of calcium flux and promotion of catecholamine release, all contributing to its bronchodilatory and immunomodulatory properties in respiratory diseases.